Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 06  •  04:00PM ET
25.47
Dollar change
+0.35
Percentage change
1.39
%
IndexRUT P/E- EPS (ttm)-2.68 Insider Own66.67% Shs Outstand51.45M Perf Week3.24%
Market Cap1.49B Forward P/E- EPS next Y-2.12 Insider Trans-0.06% Shs Float19.45M Perf Month-4.28%
Enterprise Value1.36B PEG- EPS next Q-0.60 Inst Own31.06% Short Float11.59% Perf Quarter-3.89%
Income-137.85M P/S20.01 EPS this Y55.05% Inst Trans1.63% Short Ratio7.17 Perf Half Y72.68%
Sales74.26M P/B7.99 EPS next Y8.28% ROA-70.41% Short Interest2.25M Perf YTD-3.96%
Book/sh3.19 P/C8.47 EPS next 5Y31.93% ROE-136.96% 52W High30.00 -15.10% Perf Year-
Cash/sh3.01 P/FCF- EPS past 3/5Y-18.44% - ROIC-66.01% 52W Low13.25 92.23% Perf 3Y-
Dividend Est.- EV/EBITDA- Sales past 3/5Y179.99% - Gross Margin46.40% Volatility5.96% 6.15% Perf 5Y-
Dividend TTM- EV/Sales18.25 EPS Y/Y TTM-41.97% Oper. Margin-174.32% ATR (14)1.46 Perf 10Y-
Dividend Ex-Date- Quick Ratio5.27 Sales Y/Y TTM62.06% Profit Margin-185.63% RSI (14)53.64 Recom1.29
Dividend Gr. 3/5Y- - Current Ratio5.47 EPS Q/Q-33.41% SMA204.91% Beta- Target Price29.00
Payout- Debt/Eq0.27 Sales Q/Q53.40% SMA500.58% Rel Volume0.81 Prev Close25.12
Employees330 LT Debt/Eq0.27 EarningsDec 11 AMC SMA20015.76% Avg Volume314.30K Price25.47
IPOMar 06, 2025 Option/ShortNo / Yes EPS/Sales Surpr.-7.73% 8.93% Trades Volume254,143 Change1.39%
Date Action Analyst Rating Change Price Target Change
Nov-18-25Initiated BTIG Research Buy $32
Mar-31-25Initiated Wolfe Research Outperform $29
Mar-31-25Initiated Wells Fargo Overweight $28
Mar-31-25Initiated Stifel Buy $28
Mar-31-25Initiated Piper Sandler Overweight $27
Mar-31-25Initiated Goldman Neutral $24
Mar-31-25Initiated BofA Securities Buy $30
Jan-14-26 11:05AM
Jan-13-26 06:00AM
Dec-30-25 06:00AM
Dec-12-25 12:00AM
Dec-11-25 04:01PM
05:36AM Loading…
05:36AM
04:29AM
Dec-10-25 07:15AM
Dec-03-25 08:00AM
Dec-02-25 10:11PM
Dec-01-25 07:16AM
07:01AM
Nov-10-25 09:52AM
Nov-04-25 08:00AM
Oct-28-25 08:00AM
08:00AM Loading…
Oct-07-25 08:00AM
Sep-25-25 08:00AM
Sep-17-25 08:00AM
Sep-12-25 03:04AM
Sep-11-25 04:01PM
04:55AM
04:13AM
Aug-28-25 08:00AM
Aug-04-25 08:05AM
Jul-31-25 08:31AM
Jul-29-25 03:20PM
Jul-17-25 08:00AM
Jul-16-25 09:28PM
03:05AM
Jul-15-25 04:01PM
08:00AM Loading…
Jul-01-25 08:00AM
Jun-23-25 08:00AM
Jun-05-25 08:00AM
May-13-25 08:00AM
Apr-30-25 08:00AM
Apr-29-25 08:00AM
Apr-23-25 08:00AM
Apr-14-25 04:01PM
Apr-02-25 04:05PM
Mar-14-25 04:05PM
Mar-07-25 05:30PM
Mar-05-25 11:03PM
Feb-26-25 08:00AM
Kestra Medical Technologies Ltd. is a commercial-stage, wearable medical device and digital healthcare company. It focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company was founded by Brian Webster and Traci S. Umberger in 2014 and is headquartered in Kirkland, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Webster Brian DanielSee RemarksJan 15 '26Sale22.8015,000342,024394,786Jan 20 06:00 AM
Webster Brian DanielOfficerJan 15 '26Proposed Sale22.8015,000342,024Jan 15 04:20 PM
Umberger Traci SSee RemarksDec 29 '25Sale26.6910,500280,201136,633Dec 31 04:16 PM
Webster Brian DanielSee RemarksDec 29 '25Sale26.5915,000398,847409,786Dec 31 04:14 PM
Umberger Traci SOfficerDec 29 '25Proposed Sale26.6910,500280,201Dec 29 04:36 PM
Webster Brian DanielOfficerDec 29 '25Proposed Sale26.5915,000398,847Dec 29 04:35 PM
COHEN RAYMOND WDirectorMar 07 '25Buy17.0017,000289,00029,994Sep 08 05:38 PM